General Information


DRACP ID  DRACP04470

Peptide Name  

Sequence  RGDfK

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C18H32N8O6

Absent amino acids  ACEFHILMNPQSTVWY

Common amino acids  DGKR

Mass  52803

Pl  9.69

Basic residues  2

Acidic residues  1

Hydrophobic residues  0

Net charge  1

Boman Index  -2825

Hydrophobicity  -246

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30732943

Title  Design and synthesis of novel dual-cyclic RGD peptides for 伪v尾3 integrin targeting

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20031

DRACP is developed by Dr.Zheng's team.